Figure 2. Solicited Local and Systemic Adverse Reactions, According to Grade.
Shown are the percentages of participants in whom solicited local or systemic adverse reactions occurred within 7 days after the booster dose in the solicited safety set (351 participants in the mRNA-1273 group and 437 participants in the mRNA-1273.214 group). For some systemic adverse reactions, data were available for 350 participants in the mRNA-1273 group.